OOIR: Observatory of International Research

Papers

(The median citation count of HIV Medicine is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
	148
Issue Information	94
	75
	70
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co‐administration	49
HIV ‐1 viral load and reservoir size remain stable following SARS ‐ CoV	46
Issue Information	46
Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany	43
Disparities in HIV continuum of care in the paediatric population: A real‐life study in Brazil	43
HIV testing in primary care in a low‐prevalence area of Northeast England	39
Late diagnosis of HIV infection in Warsaw: Estimating the scale of the problem and demographic trends	37
Telemedicine in HIV health care during the COVID‐19 pandemic: An implementation research study in Buenos Aires, Argentina	32
Perspectives of people with HIV and HIV clinicians on characteristics of antiretroviral treatment and HIV‐related symptoms	31
Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV	30
HIV cure: Are we going to make history?	27
User‐reported outcomes of long‐acting injectable PrEP with Cabotegravir: Real‐world experience from Milan	23
Cellular and humoral response after mRNA SARS‐CoV‐2 vaccination in kidney transplant recipients living with HIV: A cross‐sectional study	22
Aetiology of fever of unknown origin in people living with HIV : A systematic review and meta‐analysis	22
Predictors of discontinuing injectable cabotegravir/rilpivirine and virologic outcomes after resuming oral antiretroviral therapy	21
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV‐specific risk factors; the Archi‐Prevaleat project	21
Areas with high HIV prevalence: A spatial analysis of nationwide claims data in Germany	20
Effects of transition from paediatric to adult HIV care on virological outcomes in sub‐Saharan Africa: A systematic review and meta‐analysis	20
Loneliness and social isolation in people with HIV aged ≥50 years. The No One Alone (NOA)‐GeSIDA study conducted by the GeSIDA 12021 study group	19
	18
	18

Issue Information	18
Using an automated decision support tool to improve HIV prescribing: A feasibility study	17
Assessment of targeted intervention programme under the National AIDS Control Program among men who have sex with men in India	17
Issue Information	17
Compassionate use of long‐acting cabotegravir plus rilpivirine for people living with HIV‐1 in need of parenteral antiretroviral therapy	16
Issue Information	16
Influence of physical activity on endothelial function in people living with HIV	16
Exploring the cascade of mental healthcare among people with HIV experiencing depressive symptoms in the UK and Ireland: The POPPY study	16
The effect of HIV and mpox co‐infection on clinical outcomes: Systematic review and meta‐analysis	15
Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort	15
No increased risk of tuberculosis‐related immune reconstitution inflammatory syndrome with integrase inhibitor‐based antiretroviral therapy in people withHIV with profound immunosuppression	15
British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of non‐tuberculous mycobacteria 2024	15
Associations between HIV infection and frailty status and its individual components: Are frailty components disproportionally affected?	14
The value of herpes zoster prevention in people aging with HIV: A narrative review	14
Dual drivers of polypharmacy in people with HIV : Quantifying the independent associations of aging and long‐term antiretroviral therapy	14
Prescribing patterns of antiretroviral treatments during pregnancy for women living with HIV in Canada 2004–2020: A surveillance study	14
Exploring implementation considerations forgeriatric‐HIVclinics: A secondary analysis from a scoping review onHIVmodels of geriatric care	14
Changing prevalence and risk factors for Toxoplasma gondii seropositivity and disease in persons with HIV	13
Are there additional adverse effects of testosterone use among men living with HIV?—Data from the PUSH! study	13
Oral Abstracts	13
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real‐world setting in Belgium	13
	13
The first AI‐based Chatbot to promote HIV self‐management: A mixed methods usability study	13
Efficacy and safety of dolutegravir/rilpivirine in real‐world clinical practice. GeSIDA study 1119	13
	12
Issue Information	12
	12
Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real‐world cohort analysis	11
Issue Information	11
Viral rebound on antiretroviral therapy in France according to region of origin, sex, and HIV acquisition group. Results from the French Hospital Database on HIV (ANRS CO4	11
Response to letter by Kumar et al. on “Exploring the cascade of mental health care among people with HIV experiencing depressive symptoms in the UK and Ireland: The POPPY	11
AI in medicine: No longer the future, but the present	11
Gender equality in leadership of HIV care cascade clinical trials: A methodological study	11
Stigma, depression and pillbox return among adults living with HIV in rural Tanzania: A prospective cohort study	10
Access to care and impact on HIV treatment interruptions during the COVID‐19 pandemic among people living with HIV in British Columbia	10
Temporal network analysis of comorbidities among people with HIV in South Carolina	10
	10
“Editorial comment on: Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study”	10
Long‐acting injectable cabotegravir and rilpivirine in observational cohort studies: A systematic review on virological failure, resistance and re‐suppression outcomes in virally suppressed individual	10
	9
Predictors of poor health‐related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project	9
Blood pressure and metabolic outcomes after efavirenz‐ or dolutegravir‐based therapy started in acute HIV infection	9
	9
	9
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy	9
Index	9
Increasing HIV early diagnosis by implementing an automated screening strategy in emergency departments	9
Oral Abstracts	9
Knowledge and HIV‐related stigma among Portuguese healthcare professionals: A cross‐sectional analysis	9
De‐simplifying antiretroviral therapy from a single‐tablet to a two‐tablet regimen: Acceptance, patient‐reported outcomes, and cost savings in a multicentre study	9

Biomarkers of inflammation and coagulation predict non‐AIDS‐defining events in a prospective cohort of virologically suppressed people living with HIV	8
Author Index	8
Rapid start with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment in people with human immunodeficiency virus‐1 (HIV‐1): A systematic literature rev	8
Towards inclusive HIV cure development: Identifying important and acceptable HIV cure attributes a	8
The role of HIV as a risk modifier for coronary endothelial function in young adults	8
Polypharmacy in HIV : Rethinking what counts and why it matters	8
Blood‐borne virus testing in emergency departments – a systematic review of seroprevalence, feasibility, acceptability and linkage to care	8
Pneumocystis jirovecii pneumonia–Immune reconstitution inflammatory syndrome: A review of published cases	8
Clinical significance and management of low‐level HIV viremia in the era of integrase strand transfer inhibitors	8
An updated systematic review of HIV‐associated cryptococcal meningitis treatment strategies	8
Late diagnosis of human immunodeficiency virus ( HIV ) and its associated factors in Asian countries: A systematic review	8
Long‐acting cabotegravir and rilpivirine in people with HIV and obesity: Real‐world outcomes from the RELATIVITY	8
Issue Information	8
Availability and stock‐outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda	8
HCV incidence in people with HIV in southwest China: A retrospective cohort study (2004–2023)	8
Frequent hepatitis B surface antigen ( HBsAg) clearance during tenofovir therapy in persons with HIV	8
Clinical management of detectable viraemia during CAB / RPV long‐acting therapy: Are really	7
Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir‐based dual therapy. Bi‐lipid study	7
Examination of factors associated with mental health of people living with HIV in Kazakhstan: A cross‐sectional study based on the two‐continua model	7
Sex differences in cardiovascular disease and associated factors in people living with HIV : Evidence from All of Us program	7
Y181C ‐associated virologic failure during long‐acting injectable cabotegravir/Rilpivirine in a patient engaged in intensive intravenous Chemsex	7
Impact of the COVID ‐19 pandemic on missed opportunities for diagnosis of HIV infection:	7
Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV	7
Virtual care pathways for people living with HIV: A mixed‐methods systematic review	7
Point‐of‐care nucleic acid testing – a step forward in controlling the HIV epidemic: A review	7
Frailty and frailty screening: A qualitative study to elicit perspectives of people living with HIV and their healthcare professionals	7
Immune response to ART initiation in advanced HIV infection	7
Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study	7
“Real world” efficacy of bulevirtide in HBV/HDV‐related cirrhosis including people living with HIV: Results from the compassionate use programme at INMI Spa	7
Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV‐1 vaccine formulations	7
Cardiovascular risk knowledge stratified by predicted cardiovascular risk level among people living with HIV attending a tertiary	7
Highlights from the 20th European AIDS Conference: 15–18 October 2025, Paris, France	7
Supporting long‐term engagement in HIV clinical care: Learning from the COVID ‐19 pandemic	7
Intergenerational sex and early sexual debut are associated with HIV infection among transgender women in Paraguay	6
Issue Information	6
Pharmacovigilance study of INSTIs associated with weight gain and glucose/lipid metabolism adverse events based on the FDA	6
The effect of Biktarvy (B/F/ TAF ) on whole‐body insulin sensitivity, lipid and endocrine profile in healthy volunteers	6
	6
Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing	6
Sleep deficiency among people living with human immunodeficiency virus: A growing challenge	6
Potential drug–drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical survey	6
Issue Information	6
Anticholinergic medications associated with falls and frailty in people with HIV	6
CROI 2024 BHIVA working group summary	6
Incidence and predictors of attrition from HIV treatment among adults living with HIV in high‐caseload facilities following implementation of universal test and treat strategy in	6
Assessing weight change in adolescents and young adults with perinatally acquired HIV and integrase inhibitor use	6
Sexual dysfunction care needs of gay, bisexual, and other men who have sex with men living with HIV in Montreal, Canada	6
Strategies to achieve the UNAIDS 95% HIV diagnosis target in Australia: Insights from a multidisciplinary roundtable	6
Issue Information	6
Spatial and temporal trends in HIV / AIDS burden among South Asian countries from 1990 to 2021: A	6
Scars are frequently found as late sequelae in individuals affected by the 2022 mpox outbreak	6
Late diagnosis of HIV: An updated consensus definition	6
Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross‐sectional analysis in Chongqing, China	6
‘We want it all’:ARTpreferences assessed byDesirability ofOutcomeRanking	6
A cross‐sectional comparison of the use of frailty assessment tools in older people living with HIV	6
Factors associated with uptake of gynaecological care and cervical cancer screening among women in the Swiss HIV Cohort Study	5
Efficacy of dolutegravir + lamivudine q.d. with food in people with TB/HIV using a rifampicin‐based regimen: A retrospective observational case series	5
The outcomes of anxiety and depression symptom screening in a population with HIV : Insights from an HIV	5
Perceived disabling physical pain and suicidal ideation in aging people living with HIV cured of hepatitis C	5
Issue Information	5
	5
Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)	5
Implementation of frailty screening for older people living with HIV in Brighton, UK	5
Worldwide changes in HIV ‐related stigma among people living with HIV : A cross‐temporal meta‐anal	5
Trends in preterm birth in women living with HIV in Switzerland over the last three decades: A multicentric, prospective, cohort study	5
Correction to ‘Abstracts of the 19th European AIDS Conference (# EACS2023 ), October 18–21, 2023,	5
Cervical intraepithelial neoplasia progression and regression among women living with HIV in Zambia	5
Issue Information	5
Optimizing statin prescriptions for people living with HIV: Evidence for improved communication and shared care between primary care and specialist HIV	5
Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black and Hispanic/Latine adults with HIV‐1 initiating first‐line therapy: 5‐year follow‐up from two phase III stud	5
Real‐world efficacy of bictegravir/emtricitabine/tenofovir alafenamide regimen in patients infected with HIV‐1 sub‐subtype A6 harbouring the L74I mutation	5
	5
Issue Information	5
Lipid nanoparticles in antiretroviral therapy: A nanotechnology breakthrough for HIV/AIDS treatment	5
Treatment durability, satisfaction and quality of life in virologically suppressed HIV ‐1 people switching to doravirine: Results from the French stu	5
Impact of HBV serological status on HIV virological efficacy of two‐drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with	5
Sexually transmitted and blood‐borne infection risk reduction with methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder: Findings from a Canadian pragmatic rand	5
Cost of non‐communicable diseases in people living with HIV in the Central Denmark Region	5
What are the predictors of change in multimorbidity among people with HIV? A longitudinal observational cohort study	5
	5

Impact of the COVID‐19 pandemic on the HIV care continuum and associated factors in middle‐income countries: A mixed‐methods systematic review	5
One for all, all for one: neuro‐HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV	5
Issue Information	5
SARS‐CoV‐2 vaccine immunogenicity for people living with HIV: A systematic review and meta‐analysis	5
High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence	5
Factors influencing the quality of life and social skills of children living with HIV: A case–control study	5
Implementing the National Vaccination Plan in people with HIV in Italy	5
Natural occurrence of drug resistance mutations to the HIV ‐1 capsid inhibitor lenacapavir	5
Molecular epidemiological analysis and investigation of antiretroviral drug resistance profile, including capsid inhibitors, among treatment‐naïve individuals with HIV	4
PrEP for women in Europe: a systematic literature review	4
HIV and fracture: Risk, assessment and intervention	4
Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025	4
Asian participants' experience in phase 3/3b studies of long‐acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96	4
Hypertriglyceridaemia and gender differences in the risk of major adverse cardiovascular events in people with HIV : A single‐centre retrospective lo	4
	4
	4
Issue Information	4
Risk factors, management, and HPV genotyping of vulvar intraepithelial neoplasia ( VIN ) in women	4
Comorbidities, comedications and potential drug–drug interactions among people living with HIV in China	4
	4
Bictegravir/emtricitabine/tenofovir alafenamide in paediatrics: Real‐life experience from a French cohort (2019–2023)	4
Issue Information	4
Cytomegalovirus infection among people living with HIV in Sweden: Case profiles, treatment strategies and patient outcomes at Karolinska University Hospital 2010–2020	4
BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia‐Pacific region	4
Effectiveness and safety of two‐drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor in a cohort of virologically suppressed people with HIV	4
Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies	4
Issue Information	4
	4
	4
	4
The impact of accumulating immune adaptation in circulating strains of HIV ‐1	4
Potential drug–drug interactions in males living with HIV who use drugs to treat lower urinary tract symptoms	4
Late diagnosis of HIV in 2022: Why so little change?	4
Low‐level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression	4
	4
Frailty in people 50 years or older living with HIV: A sex perspective	4
HIV treatment strategies across Central, Eastern and Southeastern Europe: New times, old problems	4
Erratum	4
	4
Issue Information	4
An overview of consent requirements for HIV and viral hepatitis B and C testing in Europe	4
Individual characteristics and time‐updated factors associated with antiretroviral treatment interruptions among people living with HIV in British Co	4
Recognizing International Women's Day 2026	4
Twelve‐month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real‐world insights from BICSTaR cohorts	4
Switch to a raltegravir‐based antiretroviral regimen in people with HIV and non‐alcoholic fatty liver disease: A randomized controlled trial	4
Systematic screening for age‐related comorbidities: Health care optimization among persons with HIV in an outpatient setting	3
Issue Information	3
Taxonomic and functional profile of the anorectal microbiota in HIV‐positive and HIV‐negative men who have sex with men, using a metagenomic approach	3
	3
Strategies for strengthening same‐day ART initiation, tracing people living with HIV lost to follow‐up and viral load monitoring mechanisms in Ethiopia	3
Anal cancer screening in men who have sex with men living with HIV : The pilot of anal screening study ( PASS	3
No evidence of asymptomatic monkeypox infection in a highly sexually active MSM population in Austria	3
European Guidelines on HIV and breastfeeding: “Same, same, but different” ‐ Results from a WAVE survey	3
Long‐term immune reconstitution patterns and influencing factors in people living with HIV exhibiting suboptimal immune response after 24 months of a	3
Late diagnosis of HIV persists in Sweden: Differing social determinants among migrant and non‐migrant people with HIV	3
The recent natural history of human papillomavirus cervical infection in women living with HIV: A scoping review of meta‐analyses and systematic reviews and the construction of a hypothetic	3
Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing of antiretroviral treatment (	3
Network analysis to prioritize issues for intervention to improve the health‐related quality of life of people with HIV in Spain	3
Immunological and virological response to fostemsavir in routine US clinical care: An OPERA cohort study	3
Real‐world experience with weight gain among pregnant women living with HIV who are using integrase inhibitors	3
Commentary on ‘Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)’	3
Issue Information	3
Issue Information	3
HIV pre‐exposure prophylaxis services, provision, and delivery in the European treatment network of HIV, hepatitis and global emerging infectious diseases (NEAT ID)	3
Metabolic syndrome and Pathobiological Determination of Atherosclerosis in Youth risk score in adolescents with and without perinatally acquired HIV	3
Clinically recognized sleep disorders in people living with HIV	3
People with HIV and healthcare workers views on screening for cognitive impairment in people with HIV: A qualitative study	3
Advanced HIV disease: A review of diagnostic and prophylactic strategies	3
Transitions in treatment: A systematic review and meta‐aggregation of preferences and barriers in switching from oral to long‐acting injectable antiretroviral therapy among people living with HIV	3
Severe ocular Mpox in person living with advanced HIV treated with extended course of tecovirimat	3
Comprehensive geriatric assessment for people living with HIV and frailty: A mixed‐methods feasibility randomized controlled trial	3
Issue Information	3
	3
	3
Correction to “Perception of medical care among women living with HIV aged 40 years or older—a European‐wide survey”	3
The use of non‐invasive imaging modalities for the assessment of skeletal muscle quantity and quality in people with HIV: A narrative review	3
Scaling HIV self‐testing to improve health equity among cisgender gay, bisexual and other men who have sex with men, trans and gender‐diverse people	3
A qualitative study of perspectives, experiences and priority outcomes for people living with HIV and frailty	3
	3
	3
A call for health systems to monitor the health‐related quality of life of people living with HIV	3
Prevalence of osteoporosis in people living with HIV and risk factors associated in the cART era	3
Collection of menopause data in studies of women living with HIV: A systematic literature review	3
Issue Information	3
Authors' Reply to Letter to the Editor Regarding ‘Effectiveness, safety, and patient‐reported outcomes of emtricitabine/tenofovir alafenamide‐based regimens for the treatment of HIV‐1 infection: Final	3
Issue Information	3
People diagnosed with HIV before continuing care in England are extremely unlikely to pass on HIV	3
Patients re‐engaging with HIV care in Guatemala: Prioritizing CD4 counting and screening for histo	3
Clinical outcomes of long‐acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real‐world data from the Spanish	3
Rapid HIV pre‐exposure prophylaxis (PrEP) initiation is safe and feasible: Experience from Wroclaw All Saints cohort in Poland 2017–2021	3
Late diagnosis of HIV among Ukrainian refugees in the Czech Republic: A retrospective, observational study	3
Breaking down global barriers: A multinational and multi‐community approach to combat stigma and enhance mental wellbeing in people with HIV	3
	3
EACS Abstract 2025	3
Oral abstracts	3